Reading, MA, United States of America

Roger Frechette

This inventor holds 24 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Tetracycline Compounds. Top assignees: Paratek Pharmaceuticals, Inc., Tufts University, Biota Scientific Management Pty Ltd. Active years: 2004-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roger Frechette. Retrieved from https://idiyas.com/inventor/roger-frechette

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 24 

% Patents Active = 25.0


 

Average Co-Inventor Count = 4.6

ph-index = 9

Forward Citations = 545(Granted Patents)


Company Filing History:


Years Active: 2004-2016

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Tetracycline Compounds
Minocycline
Aminoacyl
Bicyclic PPAT Inhibitors
Heterocyclyl
Pyrazolyl
Polypeptide Binding
Carbamate
Urea
Thiocarbamate
Antibacterial Agents
Methods of Use
24 patents (USPTO):Explore Patents

Title: Roger Frechette: Pioneering Inventor from Reading, MA

Introduction: Roger Frechette is a distinguished inventor hailing from Reading, MA, known for his groundbreaking contributions to various fields.

Latest Patents: Roger Frechette holds several patents in the areas of technology, healthcare, and consumer products, showcasing his versatility and innovative spirit.

Career Highlights: With a career spanning over two decades, Roger Frechette has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have impacted industries worldwide.

Collaborations: Throughout his career, Roger Frechette has collaborated with leading companies, research institutions, and universities, fostering a culture of innovation and knowledge sharing.

Conclusion: Roger Frechette's passion for innovation and his relentless pursuit of excellence continue to inspire aspiring inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…